EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Linker Composition on VHL PROTAC Cell Permeability

Yordanos Esubalew Abeje, Lianne H E Wieske iD, Vasanthanathan Poongavanam iD, Stefanie Maassen, Yoseph Atilaw, Philipp Cromm, Lutz Lehmann, Mate Erdelyi iD, Daniel Meibom iD, Jan Kihlberg iD

Journal of Medicinal Chemistry · 09.01.2025 · 68 (1) · 638-657

DOI: 10.1021/acs.jmedchem.4c02492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.12.2024. Verfasst von Yordanos Esubalew Abeje und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry─BMC, Uppsala University, Box 576, 75123 Uppsala, Sweden. Hauptthemen laut MEDLINE: Von Hippel-Lindau Tumor Suppressor Protein, Cell Membrane Permeability, Proteolysis. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsr?det, Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of cell permeable and orally bioavailable von Hippel-Lindau (VHL) proteolysis targeting chimeras (PROTACs) is challenging as their structures locates them at, or beyond, the outer limits of oral druggable space. We have designed a set of nine VHL PROTACs and found that the linker had a profound impact on passive cell permeability. Determination of the solution ensembles in a nonpolar solvent revealed that high permeability was correlated to the ability of the PROTACs to adopt folded conformations that have a low solvent accessible 3D polar surface area. Our results suggest that the design of cell permeable VHL PROTACs could focus on linkers that facilitate shielding of polar surface area in the VHL ligand in a nonpolar but not in a polar environment. In addition, we found that not only intramolecular hydrogen bonds, but also NH-π and π-π interactions contribute to the stabilization of low-polarity conformations, and thereby to high cell permeability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Von Hippel-Lindau Tumor Suppressor ProteinCell Membrane PermeabilityProteolysisHumansLigandsHydrogen Bonding

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinVHL protein, humanLigands

Autor:innen und Institutionen

  • Department of Chemistry─BMC, Uppsala University, Box 576, 75123 Uppsala, Sweden.
  • Bayer AG, Drug Discovery Sciences, 42113 Wuppertal, Germany.

ORCID-Profile: Lianne H E Wieske, Vasanthanathan Poongavanam, Mate Erdelyi, Daniel Meibom, Jan Kihlberg

Förderung

  • Vetenskapsr?det
  • Bayer

Zitieren

APA

Abeje, Y. E., Wieske, L. H. E., Poongavanam, V., Maassen, S., Atilaw, Y., Cromm, P., Lehmann, L., Erdelyi, M., Meibom, D., & Kihlberg, J. (2025). Impact of Linker Composition on VHL PROTAC Cell Permeability. Journal of Medicinal Chemistry, 68(1), 638-657. https://doi.org/10.1021/acs.jmedchem.4c02492

Vancouver

Abeje YE, Wieske LHE, Poongavanam V, Maassen S, Atilaw Y, Cromm P, et al. Impact of Linker Composition on VHL PROTAC Cell Permeability. Journal of Medicinal Chemistry. 2025;68(1):638-657. doi:10.1021/acs.jmedchem.4c02492

BibTeX
@article{Abeje2025,
  author = {Abeje, Yordanos Esubalew and Wieske, Lianne H E and Poongavanam, Vasanthanathan and Maassen, Stefanie and Atilaw, Yoseph and Cromm, Philipp and Lehmann, Lutz and Erdelyi, Mate and Meibom, Daniel and Kihlberg, Jan},
  title = {Impact of Linker Composition on VHL PROTAC Cell Permeability},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {1},
  pages = {638--657},
  doi = {10.1021/acs.jmedchem.4c02492}
}
Kostenlos starten →